POOLBEG PHARMA PLC (POLB) — Company Presentation

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the POLBEG PHARMA PLC Company presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged and they can be submitted at any time using the Q and A tab situated on the right hand corner of your screen. Simply type in your questions and press send. The company may not be in a position to answer every question received during the meeting itself. However, the company can review all questions submitted today on published responses, which is appropriate to do so. Before we begin, I would like to submit the following poll. And I would now like to hand you over to Co Founder, Executive Chairman, Carl Friel. Good afternoon to you. Good afternoon. Thank you very much. I'd like to thank everybody for joining our call this evening. I see we've got nearly 200 people online, which is well, fabulous turnout. What we want to tell you tonight is about two hugely excited trials that we're kicking off momentarily over the summer, our GLP one obesity trial, and really importantly, our one oncology treatment trial, which is utterly transformational for us. Earlier today, just to let you know, in case you didn't see, we did complete our oversubscribed fundraise of over 4.8, almost 4,900,000. And that will fully fund those trials and fully fund the company right in the 2027. I personally invested a 100,000 in that placing. That's on top of 100,000 I invested last year. And at the IPO, I also spent over £500,000 starting at full IPO price. I know the price is not where we want it, but I've now £700,000 real personal cash invested in POLBEG. Therefore, I think my goals are pretty clearly aligned with all of you shareholders. And I'm very, very excited and thrilled to be in the position POLBEG is where it i...